Metacognitive Therapy for Obsessive-Compulsive Disorder
NCT ID: NCT02867449
Last Updated: 2021-09-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
74 participants
INTERVENTIONAL
2016-06-30
2020-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Exploring The Metacognitive Beliefs in OCD: A Randomized Controlled Trial of Metacognitive Therapy
NCT07052812
Enhancing the Acceptability of Psychological Treatments for Obsessive-compulsive Disorder
NCT03661905
Mechanisms of Exposure Therapy for OCD
NCT06173752
Exposure and Response Prevention Therapy for Obsessive-compulsive Disorder
NCT02602886
Fear Extinction and Mechanisms of Change in Obsessive Compulsive Disorder
NCT02467374
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Metacognitive Therapy
Metacognitive Therapy for OCD according to Wells (1997)
Metacognitive Therapy
Metacognitive Therapy for OCD according to Wells (1997)
Exposure and Response Prevention
Exposure and Response Prevention for OCD according to Kozak \& Foa (1997)
Exposure and Response Prevention
Exposure and Response Prevention for OCD according to Kozak \& Foa (1997)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Metacognitive Therapy
Metacognitive Therapy for OCD according to Wells (1997)
Exposure and Response Prevention
Exposure and Response Prevention for OCD according to Kozak \& Foa (1997)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* German-speaking
* Agreeing to participate, verified by completion of informed consent
* Stable medication (at least 4 weeks)
Exclusion Criteria
* Mental retardation
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Philipps University Marburg
OTHER
German Research Foundation
OTHER
University of Leipzig
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cornelia Exner
Prof. Dr. Cornelia Exner
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Cornelia Exner, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
Leipzig University
Julia A. Glombiewski, Dr.
Role: PRINCIPAL_INVESTIGATOR
Philipps University Marburg
Alexandra Kleiman, Dr.
Role: STUDY_DIRECTOR
Leipzig University
Anke Haberkamp, Dr.
Role: STUDY_DIRECTOR
Philipps University Marburg
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Leipzig University
Leipzig, , Germany
Philipps University Marburg
Marburg, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MCT_OCD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.